HI
AERI

HBK Investments’s Aerie Pharmaceuticals AERI Stock Holding History

HBK Investments’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-126,130
Closed -$2.42M – 772
2019
Q3 		$2.42M Buy
+126,130
New +$2.89M 0.03% 376
2017
Q3 		– Sell
-40,800
Closed -$2.14M – 1152
2017
Q2 		$2.14M Buy
+40,800
New +$1.9M 0.01% 398
2015
Q2 		– Sell
-16,441
Closed -$515K – 1144
2015
Q1 		$515K Buy
+16,441
New +$477K ﹤0.01% 726

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HBK Investments's AERI Position: Q4 2019 in Review

HBK Investments sold out of Aerie Pharmaceuticals (AERI) in Q4 2019, closing a stake of 126,130 shares — an estimated $2.42M sold.

HBK Investments first reported a position in AERI in Q1 2015 and held it in 3 quarters. The position peaked at $2.42M in Q3 2019. 167 funds tracked by Wall St. Rank hold AERI as of Q4 2019.

  • HBK Investments reported no remaining Aerie Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • HBK Investments sold 126,130 Aerie Pharmaceuticals shares in Q4 2019, an estimated $2.42M.
  • HBK Investments first reported a position in Aerie Pharmaceuticals in Q1 2015 and held it in 3 quarters.
  • HBK Investments's Aerie Pharmaceuticals position peaked at $2.42M in Q3 2019.
  • 167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2019.

Based on HBK Investments's 13F filing for Q4 2019, filed 14 Feb 2020.